- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02639780
Biochemical Alterations of Stored Erythrocyte Membranes
January 1, 2022 updated by: David M Baron, MD, Medical University of Vienna
The investigators will define procoagulant properties of packed red blood cells and investigate whether packed red blood cells from certain donor populations are prone to induce procoagulant states.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
36
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vienna, Austria, 1090
- Medical University of Vienna
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
volunteers who will donate one unit of packed red blood cells
Description
Inclusion Criteria:
- group 1: healthy female volunteers 18-35 y.o.
- group 2: healthy male volunteers 18-35 y.o.
- group 3: healthy female volunteers 36-60 y.o.
- group 4: healthy male volunteers 36-60 y.o.
- group 5: female volunteers 36-60 y.o., BMI 26-45
- group 6: male volunteers 36-60 y.o., BMI 26-45
Exclusion Criteria:
- age below 18 years
- age above 60 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
healthy young female
|
the proteome of packed red blood cells will be assessed at predefined time points
|
healthy young male
|
the proteome of packed red blood cells will be assessed at predefined time points
|
healthy older female
|
the proteome of packed red blood cells will be assessed at predefined time points
|
healthy older male
|
the proteome of packed red blood cells will be assessed at predefined time points
|
obese older female
|
the proteome of packed red blood cells will be assessed at predefined time points
|
obese older male
|
the proteome of packed red blood cells will be assessed at predefined time points
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
protein expression pattern
Time Frame: week 0
|
week 0
|
protein expression pattern
Time Frame: week 2
|
week 2
|
protein expression pattern
Time Frame: week 4
|
week 4
|
protein expression pattern
Time Frame: week 6
|
week 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 1, 2015
Primary Completion (ACTUAL)
November 1, 2019
Study Completion (ACTUAL)
December 1, 2021
Study Registration Dates
First Submitted
December 21, 2015
First Submitted That Met QC Criteria
December 23, 2015
First Posted (ESTIMATE)
December 24, 2015
Study Record Updates
Last Update Posted (ACTUAL)
January 4, 2022
Last Update Submitted That Met QC Criteria
January 1, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 1043/2015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coagulation
-
Masaryk Hospital Krajská zdravotní a.s.CompletedCoagulation Disorder | Multiple Trauma | Coagulation Defect; Acquired | Coagulation Factor DeficiencyCzechia
-
HemoSonics LLCCompletedCoagulationUnited States
-
Haemonetics CorporationCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Kyowa Kirin Co., Ltd.CompletedDisseminated Intravascular Coagulation (DIC)Japan
-
University Hospital, GhentUniversity GhentCompletedHemodialysis | CoagulationBelgium
-
Hospices Civils de LyonCompleted
-
PfizerCompletedBlood CoagulationUnited States
-
Centre Hospitalier Universitaire DijonNot yet recruiting
Clinical Trials on protein expression pattern of packed red blood cells
-
University Hospital, CaenUnknownTransfusion Related ComplicationFrance
-
Rania Ali El-FarrashCompletedOxidative Stress | Blood Transfusion ComplicationEgypt
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedIron, Abnormal Blood LevelUnited States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Texas Tech University Health Sciences Center, El...CompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia Treatment | Iron Deficiency Anemia Due to Blood LossUnited States
-
Bellal A. Joseph, MD, FACSUnknown
-
Stony Brook UniversityCompletedHealthyUnited States
-
University Hospital, LilleUniversity Hospital, Rouen; Centre Hospitalier Universitaire Dijon; University... and other collaboratorsRecruitingAnemia | Extracorporeal Membrane Oxygenation | Cardiogenic Shock | Transfusion Related Complication | Oxygen DeliveryFrance
-
Central Hospital, Nancy, FranceNot yet recruitingExtracorporeal Membrane Oxygenation Complication | Transfusion Related Complication | Blood Cells Transfusion
-
University of OxfordWellcome TrustRecruitingPlasmodium Vivax InfectionThailand